News Releases

Sangamo Therapeutics Announces Presentation At The 2018 Wedbush PacGrow Healthcare Conference

RICHMOND, Calif., Aug. 10, 2018 /PRNewswire/ -- Sangamo Therapeutics, Inc. (NASDAQ: SGMO) announced today that management will present a corporate overview at the 2018 Wedbush PacGrow Healthcare Conference in New York City. The presentation is scheduled for Tuesday, August 14th at 4:15 p.m. ET.

Sangamo Therapeutics, Inc. (PRNewsfoto/Sangamo Therapeutics, Inc.)

The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will be archived on the Sangamo website following the event.

About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic therapies that transform patients' lives using the Company's platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit


SOURCE Sangamo Therapeutics, Inc.

For further information: McDavid Stilwell, 510-970-6000, x219,; Varant Shirvanian, 510-970-6000 x205,